Only the facts
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You might be right
They also stated the sell to Vector will closed by the end of March .
They talk the talk and most of the funds from Vector to immune pharmaceutical is used to pay salaries benefits and expenses.
I believe otherwise
They have missed most deadlines.
Catch me if you can with all their smoke and mirrors
Love your posting but I am saying it sarcastically
If not they are abusing the bankruptcy proceedings.
Justice moves slowly but moves ..
SMILE
18 shares for less then 8 cents Why?
I believe Dr Teper buying for a one time payment of 2.5 plus ...What a deal for him not for shareholders.
The same way they where promoting the spin off yet according to court documents it was put on hold in February.
The board of directors always wanted Dr Teper to gain control of Ceplene.
It's been all part of the smoke and mirrors
At this level only green
Super potential
WoW $53.00 traded today less then my lunch bill .
Hehehe
Are you actually kidding me right now?
At lest you make me laugh with your misleading statements
Learn to read and state facts ex Never shorted any stock and when I starting selling immune pharmaceutical I posted same.
Keep up the good work your credibility is almost zero
Swoosh
Scoop
Hehehe
Watch what happens next !
Hehehe
Additionally, in connection with the Licensing Agreement, the parties thereto agreed that Pint Gmbh, an affiliate of Pint, will separately enter into an investment agreement upon satisfaction of the condition that the commercialization of the Ceplene and the Combination Therapy has been met (defined to mean when Ceplene is commercialized by Pint together with a new product in the Territory, pursuant to which, Pint Gmbh will make to an investment of $4.0 million into Cytovia in exchange for an equity interest in Cytovia. In July 2018, a global pharmaceutical and services company announced that it acquired the ex-United States rights to the drug other than Ceplene comprising the Combination Therapy. Accordingly, the condition for the investment from Pint can no longer be satisfied.
Are you actually kidding me right now?
I brought it as a hedge against my selling of immune pharmaceutical
Swoosh
Scoop
Watch what happens next !
Icotf is treating me very well on paper
While immune pharmaceutical was very bad investment for me both on paper and actual lost.
Good thing I listened to people by selling most of my holding in immune pharmaceutical saved me over 90 thousand dollars
1.5 million shares is being offer to you already .
Swoosh
Scoop
Watch what happens next !
Hope that Letterpenny purchased your shares of immune pharmaceutical
yea yea yea
blah blah blah
Swoosh
Scoop
Watch what happens next!
Read they needed another increase in authorized shares :
We are currently authorized to issue 600,000,000 shares of common stock under our Third Amended and Restated Certificate of Incorporation, as amended. As of January 11, 2019, 133,700,690 shares of common stock were issued and outstanding, the remaining shares were reserved for issuance upon the conversion or exercise of our outstanding convertible securities and warrants. However, as of January 11, 2019, we were required to have a total of 5,375,141,758 shares of common stock reserved for issuance upon the conversion of the Series E Convertible Preferred Stock (the “Series E Stock”), the exercise of warrants related to the Series E Stock (the “Series E Warrants”), the conversion of the October Debentures, the conversion of other outstanding debentures and the exercise of the October Debenture Warrants. Accordingly, we do not currently have sufficient authorized shares of common stock available to meet our contractual obligations under these instruments.
The Great Letterpenny is buy more shares
Don't get caught up with his smoke and mirrors
All preferred shares has not been converted.
Goodnight life is good God is awesome
Have a great weekend
Did you forget about :
Immune Pharmaceuticals Inc. Announces Pricing Of $18,000,000 Public Offering Of Convertible Preferred Stock And Warrants
You are all smoke and mirrors
Never shorted ANY STOCK .
Keep changing your stories you stated that Bertilimumab is there most valuable asset now worth less then 7 million gross.
Was it in the bankruptcy court order ?
What about this :
Only if there's anything left after all of the company's creditors and preferredstockholders are made whole will common stockholders receive anything. As you might guess,common stockholders usually are wiped out completely. Most companies that go bankrupt don't have enough assets to cover their obligations.
No one is protecting shareholders interest
Interesting how they are able to file incomplete monthly report.
Immune pharmaceutical omitted completed bank statements. (Doc 310 filed 09/05/19 page 5 and Doc 309 filed 09/05/19 page 5 and this is a small example of non compliance.
Scoop
Watch what happens next !
Based on my reading I believe this section would not be utilized
Bertilimumab transaction should be completed within 10 days with no milestone payment to immune pharmaceutical.
Section 3(a)(10)2 of the Securities Act3 is an exemption from Securities Act registration for offers and sales of securities in specified exchange transactions. ... The securities must be issued in exchange for securities, claims, or property interests; they cannot be offered for cash.
Section 3(a)(10)2 of the Securities Act3 is an exemption from Securities Act registration for offers and sales of securities in specified exchange transactions.4 Before the issuer can rely on the exemption, the following conditions must be met.5
The securities must be issued in exchange for securities, claims, or property interests; they cannot be offered for cash.6
A court or authorized governmental entity7 must approve the fairness of the terms and conditions of the exchange.
The reviewing court or authorized governmental entity must:
find, before approving the transaction, that the terms and conditions of the exchange are fair to those to whom securities will be issued;8and
be advised before the hearing that the issuer will rely on the Section 3(a)(10) exemption based on the court’s or authorized governmental entity’s approval of the transaction.
The court or authorized governmental entity must hold a hearing before approving the fairness of the terms and conditions of the transaction.
A governmental entity must be expressly authorized by law to hold the hearing, although it is not necessary that the law require the hearing.
The fairness hearing must be open to everyone to whom securities would be issued in the proposed exchange.
Adequate notice must be given to all those persons.
There cannot be any improper impediments to the appearance by those persons at the hearing.
This staff legal bulletin provides the Division of Corporation Finance’s views regarding the Section 3(a)(10) exemption from the Securities Act of 1933’s registration requirements. The bulletin also expresses the Division’s views regarding the Securities Act resale status of securities that are received in certain transactions exempt from registration pursuant to Section 3(a)(10)
You got to love the last three trades
????
Order Approving Immune Pharmaceuticals Inc. and Immune Pharmaceuticals, Ltd.Memorandum of Understanding with the Committee and the Israeli Trustee Relating to the Allocation of Sale Proceeds from the Sale of the Anti-Eotaxin Assets (Related Doc # [327]). Service of notice of the entry of this order pursuant to Rule 9022 was made on the appropriate parties. See BNC Certificate of Notice. Signed on 10/23/2019. (mcp)
Enjoy your holiday
Read : Never shorted immune pharmaceutical or any stock
My purpose is to supply facts not fantasy.
Letterpenny or whoever you are today 1 I have never shorted any stock. 2 I don't post false hope and fake news
3 You have been bullish on immune pharmaceutical and anyone who followed you and never sold their holdings are down 95% .
Keep up the false hope with your baseless claims
Value of Bertilimumab was peg at 1 billion dollars sold for 6 million plus liability of 750 thousand
Short never I would have shorted ECOR where Tony is now ..
LK will never be a winner here but is hoping someone will read his post and take a gamble on the red brick road.
If you followed LK hype you would have lost over 95% ...
LK Loved Management but they destroyed they company
ZERO VALUE FOR SHAREHOLDERS
221.00 dollars traded today
That's less then dinner for 2 .
Alexion will be hiring Tony
LK Still think he was working for the best interest of the shareholders.
Oh I forgot you loved management and they are going to make millions right LK
Puff all gone
Shareholders zero
Managment winners Salaries and expenses,
We are cooked
Only hope would be a Federal Investigation.
Dollar amount traded is peanuts
Shareholders conned the yellow brick road is really a red brick road
Puff all gone
Shareholders zero
Managment winners Salaries and expenses,
We are cooked
Only hope would be a Federal Investigation.
Dollar amount traded is peanuts
Shareholders conned the yellow brick road is really a red brick road
Puff all gone
No silver lining
Shareholders zero
Managment winners Salaries and expenses,
We are cooked
Interesting reading
As I have said before there is no one looking out for shareholders interest
Therefore if this was immune most valuable assets look like a total loss.
IMO Only a regulatory action like action against Maza ..
Class action should have been done over 3 years ago imo to late ..